1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, March 2017 (p7)

Biopharmaceutical Analysis & Statistics, March 2017 (p7)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

181-210 of about 800 reports

Purchase Reports From Reputable Market Research Publishers

Innovent Biologics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2017
  • by GlobalData

Summary Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company’s product portfolio comprise monoclonal ...

  • Industries : Biopharmaceutical

Hemispherx Biopharma Inc (HEB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2017
  • by GlobalData

Summary Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. ...

  • Industries : Biopharmaceutical, Pathology

Keryx Biopharmaceuticals Inc (KERX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2017
  • by GlobalData

Summary Keryx Biopharmaceuticals Inc (Keryx) is a biopharmaceutical company which develops and commercializes innovative therapies for the treatment of renal disease. The company’s lead product Auryxia ...

  • Industries : Biopharmaceutical

Blockbuster Biologics 2016: Sales of Recombinant Therapeutic Antibodies & Proteins

  • $ 154
  • Industry report
  • March 2017
  • by La Merie Publishing

Blockbuster Biologics 2016: Sales of Recombinant Therapeutic Antibodies & Proteins This report prepared by La Merie Publishing provides a compilation of the sales data of originator recombinant therapeutic ...

  • Industries : Biopharmaceutical

Biosimilar Insulin Market Access

  • $ 5000
  • Industry report
  • March 2017
  • by Datamonitor Healthcare

Overview Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimila ...

  • Industries : Biopharmaceutical, Therapy, Pharmaceutical
  • Countries : Europe

Global Factor IX Deficiency Treatment Market 2017-2021

  • $ 3500
  • Industry report
  • March 2017
  • by Infiniti Research Limited

About Factor IX Deficiency Treatment The global factor IX deficiency treatment market is characterized by the presence of various therapeutic products provided by some of the top vendors such as Shire, ...

  • Industries : Pathology, Therapy, Biopharmaceutical
  • Countries : World, Europe

Global Erythropoietin Drugs Market 2017-2021

  • $ 3500
  • Industry report
  • March 2017
  • by Infiniti Research Limited

About Erythropoietin Drugs The global erythropoietin drugs market is expected to witness a slow growth rate during the forecast period. In 2016, EMEA dominated the market, followed by the Americas and ...

  • Industries : Biopharmaceutical
  • Countries : China, World, Europe, Japan

Global Factor VIII Deficiency Treatment Market 2017-2021

  • $ 3500
  • Industry report
  • March 2017
  • by Infiniti Research Limited

About Factor VIII Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia ...

  • Industries : Pathology, Therapy, Biopharmaceutical, Healthcare, Biotechnology, Pharmaceutical
  • Countries : United States, World

Global Biopharmaceutical Analytical Instrumentation Market, Forecast to 2022

  • $ 4950
  • Industry report
  • March 2017
  • by Frost & Sullivan

Analytics Required for Biosimilar Drugs to Stimulate Market Growth The global biopharmaceutical analytical instrumentation market generated a revenue of $1,092 million in 2015 and is expected to grow at ...

  • Industries : Biopharmaceutical
  • Countries : India

Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design

  • $ 2995
  • Industry report
  • March 2017
  • by CBR Pharma Insights

Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design Summary Government support for biosimilars is increasing in key geographical ...

  • Industries : Biopharmaceutical, Generic Drug
  • Countries : World

Biosimilars in Emerging Markets

  • $ 2448
  • Industry report
  • March 2017
  • by Firstword Pharma

Description Biosimilars: Make the most of high risk emerging market opportunities Emerging biosimilars markets are currently a $5billion opportunity with even more growth potential ahead. Lower drug costs ...

  • Industries : Biopharmaceutical, Generic Drug
  • Countries : India

Fatigue - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • February 2017
  • by Global Markets Direct

Fatigue - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fatigue – Pipeline Review, H1 2017, provides an overview of the Fatigue ...

  • Industries : Pharmaceutical, Therapy
  • Countries : United States, World, Europe

Advanced Enzyme Technologies Ltd - Strategy, SWOT and Corporate Finance Report

  • $ 175
  • Company report
  • February 2017
  • by MarketLine

Advanced Enzyme Technologies Ltd - Strategy, SWOT and Corporate Finance Report Summary Advanced Enzyme Technologies Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company ...

  • Industries : Biopharmaceutical
  • Countries : United States, India

Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report

  • $ 175
  • Company report
  • February 2017
  • by MarketLine

Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report Summary Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. ...

  • Industries : Therapy, Pharmaceutical
  • Countries : Europe

Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • February 2017
  • by Global Markets Direct

Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Microscopic Polyangiitis (MPA) – Pipeline Review, ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : World, Europe, United States

Xbrane Biopharma AB (XBRANE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Xbrane Biopharma AB (Xbrane), formerly known as Xbrane Bioscience AB, is a biotechnology company that develops and manufactures complex generics. Its product portfolio includes biosimilars and ...

XTL Biopharmaceuticals Ltd (XTLB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary XTL Biopharmaceuticals Ltd (XTL) is a biopharmaceutical company that offers acquisition, development and commercialization of pharmaceutical products and formulations. The company’s pipeline ...

  • Industries : Biopharmaceutical

Strongbridge Biopharma plc (SBBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Strongbridge Biopharma plc (Strongbridge), formerly known as Cortendo plc, is a biopharmaceutical company that offers development, in-licensing, acquisition and eventual commercialization of complementary ...

  • Industries : Biopharmaceutical

SK Biopharmaceuticals Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a pharmaceutical company that develops and markets innovative drugs for the treatment of central nervous ...

Therapure Biopharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Therapure Biopharma Inc (Therapure) is a biopharmaceutical company that offers research and development services. The company’s activities include manufacture, development, purification, and ...

  • Industries : Biopharmaceutical

Theravance Biopharma Inc (TBPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Theravance Biopharma Inc (Theravance) which discovers and develops novel medicines for various diseases.It offers a commercial product, telavancin which is a dual mechanism antibiotic.The company’s ...

  • Industries : Biopharmaceutical

Sutro Biopharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Sutro Biopharma Inc (Sutro), formerly Fundamental Applied Biology, Inc., which focuses on the development therapeutics for the treatment of cancer. The company’s pipeline product portfolio includes ...

  • Countries : United States

Sun BioPharma Inc (SNBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc, develops therapeutics for the treatment of cancer. The company’s pipeline portfolio includes SBP-101 for the treatment of pancreatic ...

  • Countries : United States

Transposagen Biopharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Transposagen Biopharmaceuticals Inc (Transposagen) is a biotechnology company that offers range of gene editing technologies and services that address the research needs of academic and drug discovery ...

Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022

  • $ 1500
  • Industry report
  • February 2017
  • by Kuick Research

“Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022” report gives comprehensive insight on clinical and non-clinical issues involved with growth of global biosimilar insulin ...

  • Industries : Therapy, Pharmaceutical, Biopharmaceutical, Generic Drug
  • Countries : World

Oncolys BioPharma Inc (4588) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers, and develops treatments for cancer and infectious diseases. The company’s pharmaceutical pipeline products include OBP-301, ...

  • Countries : Japan

Provectus Biopharmaceuticals Inc (PVCT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Provectus Biopharmaceuticals Inc (Provectus), formerly Provectus pharmaceuticals, Inc. is a biopharmaceutical company that develops pharmaceuticals for oncology and dermatology indications. The ...

  • Industries : Biopharmaceutical
  • Countries : United States

Provenance Biopharmaceuticals Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Provenance Biopharmaceuticals Corp (Provenance) is a biopharmaceutical company that focuses on that development novel immunotherapeutics to treat cancer and other serious, life-threatening diseases. ...

  • Industries : Biopharmaceutical

Principia Biopharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Principia Biopharma Inc (Principia Biopharma) is a biopharmaceutical company that designs and develops oral small molecule drug therapies. The company’s proprietary Tailored Covalency technology ...

  • Industries : Biopharmaceutical

Schnell Biopharmaceuticals Inc (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary Schnell Biopharmaceuticals Inc (Schnell), formerly Korea Schnell Pharma Co., Ltd. is a healthcare company that offers agents and antibiotics. The company provides pharmaceutical products including ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.